China Biologic Products to Attend Canaccord Genuity 30th Annual Growth Conference

PRNewswire
Jul 29, 2010

TAI'AN, China, July 29 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), one of the leading plasma-based biopharmaceutical companies in the People's Republic of China ("PRC"), operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. ("Taibang") and Guiyang Dalin Biologic Technologies Co., Ltd. ("Dalin") and its equity investment in Xi'an Huitian Blood Products Co., Ltd. ("Huitian"), today announced that Mr. Y. Tristan Kuo, the Company's Chief Financial Officer, will present at the Canaccord Genuity 30th Annual Growth Conference (the "Conference"), on August 11, 2010 at 1:00 p.m. ET. The Conference will be held from August 10-12, 2010 at the InterContinental Boston Hotel, in Boston, Massachusetts. Mr. Kuo will also be available for one on one meetings with investors and analysts at the conference.

For more information about the conference and registration, please contact Nadine Miller at nmiller@canaccordgenuity.com .

About China Biologic Products, Inc.

China Biologic Products, Inc., through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd, and its equity investment in Xi'an Huitian Blood Products Co., Ltd., is currently the largest non-state-owned plasma-based biopharmaceutical company in China. The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. The Company's plasma-based biopharmaceutical products are irreplaceable during medical emergencies, and are used for the prevention and treatment of various diseases. The Company sells its products to hospitals and other healthcare facilities in China. Please see the Company's website http://www.chinabiologic.com/ for additional information.

  For more information, please contact:

  Company Contact:
   Mr. Y. Tristan Kuo
   Chief Financial Officer
   China Biologic Products, Inc.
   Tel:   +86-538-6202206
   Email: IR@chinabiologic.com
   Web:   http://www.chinabiologic.com/

  Investor Relations Contact:
   Mr. Kalle Ahl, Account Manager
   CCG Investor Relations
   Tel:   +1-646-833-3417
   Email: kalle.ahl@ccgir.com
   Web:   http://www.ccgirasia.com/

   Mr. Crocker Coulson, President
   Tel:   +1-646-213-1915
   Email: crocker.coulson@ccgir.com

SOURCE: China Biologic Products, Inc.

CONTACT: Company Contact: Mr. Y. Tristan Kuo, Chief Financial Officer,
China Biologic Products, Inc. at +86-538-6202206 or IR@chinabiologic.com;
Investor Relations Contact: Mr. Kalle Ahl, Account Manager, CCG Investor
Relations at +1-646-833-3417 or kalle.ahl@ccgir.com; Mr. Crocker Coulson,
President, CCG Investor Relations at +1-646-213-1915 or
crocker.coulson@ccgir.com

Web site: http://www.chinabiologic.com/